Every material Form 8-K Healthcare Triangle, Inc. has filed with the SEC since September 25, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Healthcare Triangle, Inc. completed a 1-for-20 reverse stock split effective October 26, 2026, reducing its common shares outstanding from 17,730,008 to 886,587. The company said the split is intended to meet Nasdaq's $1.00 minimum bid price requirement. Nasdaq has issued a Staff Delisting Determination, and a Nasdaq Hearings Panel hearing is scheduled for November 5, 2026, with no assurance the company will keep its listing.
1-for-20 reverse split effective 12:01 a.m. ET on October 26, 2026; shares trade split-adjusted on the Nasdaq Capital Market under HCTI
Common shares outstanding reduced from 17,730,008 to 886,587; authorized shares unchanged
Nasdaq Staff Delisting Determination received October 1, 2026; company requested a Panel hearing October 8, 2026
Hearing before the Nasdaq Hearings Panel scheduled for November 5, 2026; company states there can be no assurance of continued listing
Healthcare Triangle, Inc. received a Nasdaq Staff Delisting Determination because its closing bid price has been below $1.00 and the company is not eligible for a compliance period after cumulative reverse stock splits of 1-for-14,940 over two years. The company intends to request a Panel hearing, which would stay suspension, and its shares continue to trade as HCTI for now, but without a successful appeal the stock would be suspended from Nasdaq on October 12, 2026.
Nasdaq notice dated October 1, 2026 cites failure to meet the $1.00 minimum bid price under Rule 5550(a)(2)
Company is ineligible for a compliance period after a 1-for-249 reverse split (August 1, 2025) and a 1-for-60 reverse split (February 10, 2026)
Appeal to a Nasdaq Hearings Panel must be requested by October 8, 2026; otherwise trading suspension begins October 12, 2026
Company intends to request a hearing and may propose a reverse stock split; the Panel's outcome is not assured
On September 22, 2026, Healthcare Triangle entered into a First Amendment to its June 12, 2026 Equity Purchase Agreement with Hudson Global Ventures, LLC. The amendment lowers the maximum amount that can be sold under each Put Notice from $2.5 million to $250,000 and raises the minimum price per share from $0.01 to $0.10, while adding a provision that ends the company's right to deliver Put Notices after a Change of Control Transaction.
Maximum amount per Put Notice reduced from $2.5 million to $250,000 under Section 2.1
Minimum price per share raised from $0.01 to $0.10, subject to adjustments for splits and similar events
After a Change of Control Transaction, the company no longer has the right to deliver any Put Notice
Amendment dated September 22, 2026; original agreement filed as Exhibit 10.2 to the June 15, 2026 8-K
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Healthcare Triangle, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →